ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Single vs. Double Induction With "7+3" Containing 60 vs. 90 mg Daunorubicin for Newly Diagnosed AML: Results From the Randomized Controlled SAL Dauno-Double Trial
By
ASH 2022 Conference Coverage
FEATURING
Christoph Röllig
By
ASH 2022 Conference Coverage
FEATURING
Christoph Röllig
181 views
January 4, 2023
Login to view comments.
Click here to Login
Leukemia